CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2023 Financial…
-Advisory Committee meeting for exagamglogene autotemcel (exa-cel) for the treatment of severe sickle cell disease (SCD) completed October 31, 2023; exa-cel assigned Prescription Drug User…